Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus

Status:
Terminated

Trial end date:
2004-12-01

Target enrollment:

Participant gender:

The purpose of this study was to determine the long-term safety of TAK-559, once daily (QD), in subjects with Type 2 Diabetes.

Phase 3

Takeda